Polygenic risk scores (PRSs), which often aggregate results from genome-wide association
studies, can bridge the gap between initial discovery efforts and clinical applications for the …

Because polygenic risk scores (PRSs) for coronary heart disease (CHD) are derived from
mainly European ancestry (EA) cohorts, their validity in African ancestry (AA) and Hispanic …

Purpose Assessing the risk of common, complex diseases requires consideration of clinical
risk factors as well as monogenic and polygenic risks, which in turn may be reflected in …

The exponential growth of pathogen nucleic acid sequences available in public domain
databases has invited their direct use in pathogen detection, identification, and surveillance …

Advances in technologies for assessing genomic variation and an increasing understanding
of the effects of genomic variants on health and disease are driving the transition of …

Polygenic risk scores (PRSs) have improved in predictive performance, but several challenges
remain to be addressed before PRSs can be implemented in the clinic, including reduced …

Importance Multiple polygenic risk scores (PRSs) for breast cancer have been developed
from large research consortia; however, their generalizability to diverse clinical settings is …

Genomic knowledge is being translated into clinical care. To fully realize the value, it is critical
to place credible information in the hands of clinicians in time to support clinical decision …

Gossypium mustelinum, one of five tetraploid species in the cotton genus, is geographically
restricted to a few states in NE Brazil. Allozyme analysis was used to assess levels and …

Clostridioides difficile (C. diff.) infection (CDI) is a leading cause of hospital acquired diarrhea
in North America and Europe and a major cause of morbidity and mortality. Known risk …